Non-causality in Bivariate Binary Panel Data



Saturated

Unsaturated

Model

Loglikelihood

Par.

Loglikelihood

Par.

Hu

-1472.925

-1475.488

ΓΓ

Hlw2

-1481.004

13

-1482.533

10

Hlw2

-1476.176

13

-1477.141

10

Hlw2

-1484.106

9

-1484.106

9

H11,2

-1488.5iθ~

____8

-1488.5iθ~

____8

Table 6: Likelihood of the Estimated Models

Hypothesis

LR test

dgf

p-value

Hlw2vs.Hu

14.090

1

(ШГ

Hlw2vs.Hu

3.307

Γ

0.07

Hlw2 vs. Hu

17.236

2

0.00

H11,2 vs. Hu

26.043

3~

0.00

Table 7: LR Non-Causality Tests for the Unsaturated Model

Hlw2 : Y1 → Y2,

Hlw2 -.Y2 → Y1,

Hlw2 -.Y1 → Y2, Y2 → Y1,

Я1±2 :uɪ →Y2,Y2 →Y1,Y1 φY2.

The maximized loglikelihood, together with the corresponding number of pa-
rameters, is reported in Table 6 for each of the estimated models.

It is straightforward to note that likelihood ratio tests fail to detect, at usual
significance level, any difference between a saturated model and the correspond-
ing unsaturated one. It is therefore not surprising that also the non-causality
tests yield about the same results. Table 7 reports the tests for the unsatu-
rated model. The results support the economic consideration that the previous
adoption of an FMS rises the probability of adoption of a CADCAM, while in
the opposite direction the evidence is much weaker, and statistically non sig-
nificant. In fact, the economic intuition suggests that CADCAM is a powerful
design tool even without an FMS. The strong simultaneous dependence suggest
that the decision of joint simultaneous adoption occurs more often than what
would be expected if the two decisions were taken independently.

8 Conclusions

In this paper we make a step towards rendering an important tool of applied
macroeconometric analysis, such as Granger поп-causality, available and oper-
ational for those situations in which the processes involved in the analysis are

25



More intriguing information

1. The name is absent
2. The name is absent
3. The name is absent
4. Popular Conceptions of Nationhood in Old and New European
5. The Impact of Individual Investment Behavior for Retirement Welfare: Evidence from the United States and Germany
6. The name is absent
7. The name is absent
8. ISSUES IN NONMARKET VALUATION AND POLICY APPLICATION: A RETROSPECTIVE GLANCE
9. The name is absent
10. The role of statin drugs in combating cardiovascular diseases